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Abstract We analyzed the association of neuropsychological
test impairment at baseline with the development of dementia
in idiopathic Parkinson’s disease (PD) patients. A cohort of
nondemented PD patients from northern Manhattan, NY was
followed annually with neurological and neuropsychological
evaluations. The neuropsychological battery included tests of
verbal and nonverbal memory, orientation, visuospatial ability,
language, and abstract reasoning. The association of baseline
neuropsychological tests scores with incident dementia was
analyzed using Cox proportional hazards models. The analysis
controlled for age, gender, education, duration of PD, and the
total Unified Parkinson’s Disease Rating Scale motor score at
baseline. Forty-five out of 164 patients (27%) became de-
mented during a mean follow-up of 3.7 ± 2.3 years. Four neuro-
psychological test scores were significantly associated with in-
cident dementia in the Cox model: total immediate recall (RR:
0.92, 95% CI: 0.87–0.97, P  0.001) and delayed recall (RR:
0.73, 95% CI: 0.59–0.91, P 0.005) of the Selective Remind-
ing Test (SRT), letter fluency (RR: 0.87, 95% CI: 0.77–0.99, P
 0.03), and Identities and Oddities of the Mattis Dementia
Rating Scale (RR: 0.85, 95% CI: 0.73–0.98, P 0.03). When
the analysis was performed excluding patients with a clinical
dementia rating of 0.5 (questionable dementia) at baseline
evaluation, total immediate recall and delayed recall were still
predictive of dementia in PD. Our results indicate that impair-
ment in verbal memory and executive function are associated
with the development of dementia in patients with PD. © 2002
Movement Disorder Society
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Although most patients with idiopathic Parkinson’s
disease (PD) have circumscribed cognitive impairment,
only a proportion of them develops dementia.1 Determin-
ing which neuropsychological tests are most predictive
of incident dementia in PD may provide useful prognos-
tic information. Because the pathological substrate un-
derlying dementia in PD has not been clearly defined and
some studies have suggested that the presence of con-
comitant Alzheimer’s disease (AD) cortical changes is
etiologically related to dementia in PD,2–4 the early cog-
nitive impairment associated with the development of
dementia may also provide insight into the biological
basis of PD dementia.
In longitudinal studies, age and severity of extrapyra-
midal signs have been associated most consistently with
incident dementia in PD.5–11 We reported previously that
verbal fluency tests were predictive of dementia in a
community-based sample of PD patients followed for a
mean of 2.7 years (maximum follow-up: 4 years).12 Only
one other longitudinal study of neuropsychological pre-
dictors of incident dementia in PD has been published.13
We reexamined the pattern of cognitive impairment as-
sociated with incident dementia in an expanded cohort of
PD patients with a longer duration of follow-up, includ-
ing twice the number of incident dementia cases.
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A cohort of nondemented PD patients from the Wash-
ington Heights community in northern Manhattan, NY
was followed annually with neurological and neuropsy-
chological evaluations. The ascertainment procedure and
inclusion and exclusion criteria for the cohort have been
described previously.1 We attempted complete case as-
certainment through the development of a “registry” in
the community for all individuals considered to have PD
living within four zip codes in Washington Heights–
Inwood. Patients were identified from many sources in-
cluding admission and discharge lists from the Columbia
Presbyterian Medical Center, lists from various ambula-
tory care sites, and practitioners both in the hospital and
in the community. Idiopathic PD was defined by estab-
lished research criteria.14–16 Patients with postencepha-
litic and drug-induced parkinsonism or a parkinson-plus
syndrome were excluded, as were patients who presented
memory loss or dementia before the motor manifesta-
tions of PD. No patient became demented within 1 year
of onset of motor manifestations (minimum disease du-
ration until dementia, 2.5 years), therefore clinical crite-
ria for dementia with Lewy bodies were not met.17
Of 319 patients with idiopathic PD, 105 considered to
be demented at baseline evaluation were excluded. Of
214 nondemented patients, 31 had no follow-up visit.
These 31 patients with no follow-up were less likely to
be white/non-Hispanic (25.8% vs. 54.6%, P < 0.05) than
the patients with follow-up (n  183). No statistically
significant differences were observed for age, gender,
education, duration of PD, or severity of extrapyrami-
dal signs. Three additional patients were excluded be-
cause they had signs or symptoms of stroke at baseline,
leaving 180 patients with at least two visits for the pre-
sent analysis.
Duration of PD was defined as the time period be-
tween the first symptom of PD and the baseline evalua-
tion. The annual clinical evaluation included the Unified
Parkinson’s Disease Rating Scale (UPDRS)18 on all pa-
tients, and the Hamilton Depression Rating Scale
(HDRS)19 on a subset of the patients. Functional status
was assessed by a physician blind to the neuropsycho-
logical examination using the Blessed Dementia Rating
Scale (part I),20 and functional impairment was neces-
sary for a diagnosis of dementia.
The neuropsychological battery, described in detail
elsewhere,12,21 included the following measures: total
immediate recall, delayed recall, and delayed recognition
memory of the Selective Reminding Test (SRT),22 Ben-
ton Visual Retention Test matching and recognition,23
the Similarities subtest of the Wechsler Adult Intelli-
gence Scale-Revised (WAIS-R),24 category fluency, let-
ter fluency,25 the Identities and Oddities subtest of the
Mattis Dementia Rating Scale (MDRS),26 Rosen Draw-
ing Test,27 Boston Naming Test,28 repetition and audi-
tory comprehension from the Boston Diagnostic Aphasia
Examination,29 and the orientation items of the Mini-
Mental State Examination.30 Neuropsychological test
scores were evaluated using a fixed paradigm21 and de-
mentia was diagnosed based on Diagnostic and Statisti-
cal Manual of Mental Disorders, revised third edition
(DSM-III-R)31 criteria.
Each patient was assigned a Clinical Dementia Rating
(CDR)32 at each study visit. Nondemented patients had
either CDR 0 (no dementia) or CDR 0.5 (questionable
dementia). CDR 0.5 was assigned to patients who did not
meet criteria for dementia according to a fixed para-
digm21 but whose test performance was believed to have
functional significance.
Data Analysis
Baseline characteristics of patients with and without
incident dementia were compared using Student’s t tests
for continuous variables and 2 tests for categorical vari-
ables. The association of baseline cognitive impairment
with incident dementia was studied using Cox propor-
tional hazards models. Baseline scores on 14 neuropsy-
chological tests were entered in the Cox model using a
forward stepwise procedure for the selection of predictor
variables (entry criterion: P < 0.05, removal criterion: P
> 0.1). These same neuropsychological test scores, in
addition to functional impairment, were taken into ac-
count when diagnosing dementia. Duration of follow-up
until the diagnosis of dementia or until the last visit for
those patients who did not become demented was used as
the timing variable in the Cox models. All analyses con-
trolled for age, gender, years of education, duration of
PD, and the total UPDRS motor score (Part III) at base-
line. Analyses were performed both for the entire cohort




Of 180 patients, 52 (29%) became demented during a
mean follow-up period of 3.6 ± 2.2 years (maximum
follow-up: 8 years). Baseline characteristics of the cohort
are summarized in Table 1. Patients who became de-
mented subsequently were older, less educated, and had
more severe motor signs at baseline than those who did
not become demented. No significant differences were
seen in gender, ethnicity, language in which the neuro-
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psychological tests were administered (English or Span-
ish), duration of PD, total HDRS score, use of dopami-
nergic and anticholinergic medications, and levodopa
dosage.
In addition to age at baseline and the total UPDRS
motor score, four neuropsychological tests were associ-
ated with incident dementia in the Cox regression model
with forward stepwise procedure for the selection of pre-
dictor variables: total immediate recall and delayed recall
of the SRT, letter fluency, and Identities and Oddities of
the MDRS (Table 2). Sixteen patients, 7 of whom de-
veloped dementia during follow-up, were excluded due
to missing data for one or more variables initially entered
in the model. The excluded patients were older (78.2 ±
5.7 vs. 70.3 ± 10.3 years, P < 0.001), less educated (8.2
± 5.6 vs. 11.4 ± 4.6 years, P  0.009), and more often
female (81.3% vs. 51.2%, P 0.02) than those patients
with complete data. Of the remaining 164 patients, 45
(27%) became demented during a mean follow-up of 3.7
± 2.3 years.
To aid in the clinical interpretation of the risk ratios of
the neuropsychological variables retained in the Cox
model, we dichotomized baseline performance into
scores above and below the median. The median scores
were 36 for total immediate recall (maximum possible
score, 72), 5 for delayed recall (maximum possible score,
12), 9 for letter fluency (no maximum score), and 15 for
Identities and Oddities (maximum possible score, 16).
The four dichotomous neuropsychological variables
were included in a Cox model controlling for age, gen-
der, education, duration of PD, and total UPDRS motor
score at baseline. In this analysis (total N  164; inci-
dent dementia N  45), the risk ratio for dementia as-
sociated with obtaining a score <median vs. median
(reference) was 6.5 (95% CI: 2.0–21.6, P  0.002) for
total immediate recall, 4.4 (95% CI: 1.7–11.3, P 
0.002) for delayed recall, 1.6 (95% CI: 0.7–3.5, P 0.2)
for letter fluency, and 1.3 (95% CI: 0.6–2.7, O 0.5) for
Identities and Oddities.
TABLE 2. Risk ratios for incident dementia derived from a
Cox proportional hazards model
Variable Risk ratio 95% CI P
Age at baseline (yr) 1.06 1.02–1.11 0.001
Gender (male) 1.69 0.89–3.22 0.1
Education 1.05 0.97–1.14 0.2
Duration of PD (yr) 0.98 0.93–1.04 0.5
Total UPDRS motor
score 1.06 1.03–1.10 0.0001
Total immediate recall
of the SRT 0.92 0.87–0.97 0.001
Delayed recall of
the SRT 0.73 0.59–0.91 0.005
Letter fluency 0.87 0.77–0.99 0.03
Identities and oddities
of the MDRS 0.85 0.73–0.98 0.03
Neuropsychological variables were selected using a forward step-
wise procedure; all of the above variables are simultaneously included
in the Cox model.
Total N 164, incident dementia N  45.
MDRS, Mattis Dementia Rating Scale; PD, Parkinson’s disease;
SRT, Selective Reminding Test; UPDRS, Unified Parkinson’s Disease
Rating Scale.
TABLE 1. Baseline demographic and clinical characteristics of Parkinson’s disease patients










Age, yr (S.D.) 74.6 (8.2) 69.5 (10.7)a 71.0 (10.3)
Gender (% male) 55.8 42.2 46.1
Education, yr (S.D.) 9.4 (4.6) 11.8 (4.7)a 11.1 (4.8)
Ethnicity (% white/non-Hispanic) 55.8 54.7 55.0
Primary language (% English) 52.9 65.4 61.8
Duration of PD, yr (S.D.) 7.3 (5.8) 5.9 (7.2) 6.3 (6.9)
Total UPDRS motor score,
range 0–100 (S.D.) 32.0 (13.6) 22.2 (11.4)a 25.0 (12.8)
Total 17-item HDRS score,
range 0–53 (S.D.) 6.8 (5.6) 5.8 (5.0) 6.1 (5.1)
Use of dopaminergic agents (%)b 76.9 75.8 76.1
Use of anticholinergics (%) 17.6 15.2 15.9
Levodopa dosage, mg/day (S.D.) 326.7 (325.3) 364.2 (373.6) 354.1 (360.6)
Values are expressed as mean (S.D.) or percent.
Total n: 178 for language, 177 for UPDRS score, 154 for HDRS score, 176 for use of anticholinergics, and
159 for levodopa dosage.
aP < 0.05.
bIncludes levodopa and dopaminergic agonists.
HDRS, Hamilton Depression Rating Scale; PD, Parkinson’s disease; UPDRS, Unified Parkinson’s Disease
Rating Scale.
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The initial Cox model analysis was repeated including
the total HDRS score at baseline. Twenty cases had miss-
ing information for the total HDRS score, leaving 144
patients for this analysis. Results were similar except for
the Identities and Oddities test, which was no longer
included in the final model.
Cohort Excluding CDR 0.5
Twenty-eight of 164 patients (17.1%) had a CDR of
0.5 (questionable dementia) at baseline. We performed
the analysis after excluding these patients, and the final
model retained total immediate recall, delayed recall, and
Identities and Oddities as predictors of incident demen-
tia, but letter fluency was not included in this model
(Table 3).
We recalculated the median scores of the three neuro-
psychological test scores that were predictive of incident
dementia in this subgroup (total N  136, incident de-
mentia N  25) and compared those with scores <me-
dian to those with scores median (reference). The me-
dian scores were 39 for total immediate recall, 6 for
delayed recall, and 15 for Identities and Oddities. In a
Cox model controlling for age, gender, education, dura-
tion of PD, and total UPDRS motor score at baseline,
risk ratios were 7.3 (95% CI: 0.8–62.8, P  0.07) for
total immediate recall, 12.2 (95% CI: 1.5–101.6, P 
0.02) for delayed recall, and 1.7 (95% CI: 0.6–5.2, P
0.3) for Identities and Oddities.
DISCUSSION
In this cohort, baseline impairment in verbal memory
(total immediate and delayed recall) was associated with
incident dementia in PD, in addition to impairment in
tests suggestive of executive dysfunction (letter fluency
and Identities and Oddities). In the analysis including the
total HDRS score as a covariate, the Identities and Oddi-
ties was not a significant predictor of dementia in PD,
which may imply that depressive symptoms accounted
for the association of the Identities and Oddities with
incident dementia in PD. Alternatively, this may have
been due to lower statistical power because of the loss of
patients with missing data in this analysis. In the analysis
excluding patients with CDR 0.5 at baseline evaluation,
both memory tests were still predictive of dementia in
PD, but letter fluency was not included in the model,
which may be due to the smaller sample size in this
analysis (Table 3).
In our previous study,12 baseline performance on two
verbal fluency tasks (letter fluency and category fluency)
predicted incident dementia in PD patients. Sixty-one of
164 patients who were included in the stepwise Cox
regression model were not included in the previous
analysis.12 Eight patients from the original cohort were
not included in the current analysis because they were
subsequently deemed not to have PD, or because differ-
ent criteria for the exclusion of stroke cases were em-
ployed. The demographic characteristics of the present
cohort, however, were similar to the previous cohort. Of
45 patients with incident dementia in the present analy-
sis, 21 were included as incident dementia cases in the
previous analysis, 9 became demented during the addi-
tional follow-up, and 15 were new patients not included
in the previous analysis. The duration of follow-up until
the diagnosis of dementia of these 15 patients was not
significantly different from the group of 45 patients as a
whole (2.5 ± 1.4 vs. 2.7 ± 1.7 years, P 0.7). Thus, we
believe that the additional findings in the present study
are attributable to the statistical power gained from larger
sample size and increased duration of follow-up.
In the only other published prospective study of neuro-
psychological predictors of dementia in PD,13 81 initially
nondemented PD patients were reassessed after a mean
of 3.5 years and 19 were diagnosed as demented. The
Picture Completion subtest of the WAIS-R, the interfer-
ence section of the Stroop test, and letter fluency were
considered to be independent predictors of incident de-
mentia. Three memory subtests of the Wechsler Memory
Scale (Logical Memory, Visual Memory, and Associate
Learning) were not predictors of incident dementia.
Compared to our community-based cohort, the clinic
sample used in this study was younger (66.9 ± 10.0
years), had a longer duration of PD (8.3 ± 6.5 years), and
lower total UPDRS motor score (17.9 ± 14.4).
Previous studies of cognitive impairment in early PD
TABLE 3. Risk ratios for incident dementia derived from a
Cox proportional hazards model, excluding cases with
questionable dementia (CDR 0.5) at baseline evaluation
Variable Risk ratio 95% CI P
Age at baseline 1.06 1.01–1.12 0.03
Gender (male) 1.14 0.47–2.76 0.8
Education 1.04 0.92–1.17 0.6
Duration of PD 0.97 0.91–1.02 0.2
Total UPDRS motor
score 1.08 1.03–1.13 0.002
Total immediate recall
of the SRT 0.89 0.83–0.95 0.0005
Delayed recall of
the SRT 0.70 0.52–0.93 0.01
Identities and oddities
of the MDRS 0.62 0.43–0.90 0.01
Neuropsychological variables were selected using a forward step-
wise procedure; all of the above variables are simultaneously included
in the Cox model.
Total N  136, incident dementia N  25.
CDR, Clinical Dementia Rating; MDRS, Mattis Dementia Rating
Scale; PD, Parkinson’s disease; SRT, Selective Reminding Test;
UPDRS, Unified Parkinson’s Disease Rating Scale.
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have demonstrated impaired performance in memory
tests.33–36 Yet, as stated by Levin and Katzen, “More
research is needed to examine whether early memory
impairment is a marker or precursor for a more wide-
spread dementia that will develop in the later stages of
the disease.”37 In this cohort, memory impairment in
nondemented PD patients predicted dementia in the later
stages of PD. This finding, however, may not be appli-
cable to a cohort of patients with a shorter duration of
PD. Some studies have suggested that involvement of
frontal lobe function accounts for memory impairment in
early nondemented PD patients.35,38–41 In a previous
cross-sectional analysis, we observed a qualitative dif-
ference in memory performance between nondemented
and demented PD patients, as compared to matched AD
groups.42 This finding was supported in a prospective
study of the rate of cognitive decline in AD and PD
dementia.43
In longitudinal studies of healthy elders, in addition to
impairment in delayed and immediate recall, impairment
in naming, category fluency, and Digit Symbol and Simi-
larities subtests of the WAIS-R have been shown to be
predictive of AD.44–46 Although our study evidenced
memory impairment as a precursor of dementia in PD,
the neuropsychological impairment associated with inci-
dent PD dementia in this and other studies does not over-
lap completely with that of the preclinical phase of AD.
Moreover, impairment in delayed recall reflects deficient
encoding in AD as opposed to retrieval failure in PD.47
Category fluency impairment is attributed to early dete-
rioration of semantic knowledge in AD48 and a deficit in
semantic retrieval in PD.49
Our study has limitations. The cohort consisted of in-
dividuals with a mean age at baseline of 71.0 ± 10.3
years (median: 71.8 years) and mean disease duration at
baseline of 6.3 ± 6.9 years (median: 4.2 years). There-
fore, the findings may not be applicable to younger pa-
tients or patients with earlier PD. Although there were no
statistically significant differences in medications use at
baseline evaluation between incident dementia and no
incident dementia patients, changes in medications use
during follow-up are likely to have occurred and might
have an effect in our analysis. Because cognitive impair-
ment is part of the definition of dementia, worse perfor-
mance on neuropsychological tests is expected to in-
crease the risk of dementia in PD. The association of
memory impairment with dementia in our study is not
unexpected, because DSM-III-R criteria for dementia re-
quire memory impairment. The finding that memory im-
pairment at baseline was predictive of incident dementia
might denote that patients who developed dementia dur-
ing follow-up were already in the early stages of the
dementing process. Even in the analysis that excluded
cases with questionable dementia (CDR 0.5), however,
both immediate and delayed recall predicted incident de-
mentia in PD (Table 3).
In summary, our results indicate that verbal memory
impairment and executive dysfunction predict the devel-
opment of dementia in PD. Prospective longitudinal
studies involving a cohort of younger patients or patients
with earlier PD are needed before these findings can be
generalized.
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